Copyright
©2012 Baishideng Publishing Group Co.
World J Diabetes. Jan 15, 2012; 3(1): 7-18
Published online Jan 15, 2012. doi: 10.4239/wjd.v3.i1.7
Published online Jan 15, 2012. doi: 10.4239/wjd.v3.i1.7
Table 1 Mechanisms and consequences related to protein kinase C activation-mediated harmful effects in diabetes mellitus
Reduction of nitric oxide production |
Increased endothelin-1, prostaglandin E2 and thromboxane A2 |
Induction of growth factor expression: Transforming growth factor-β and vascular endothelial growth factor |
Accumulation of microvascular matrix, fibronectin and type IV collagen |
Overexpression of fibrinolytic inhibitor plasminogen activator inhibitor-1 |
Activation of the transcription factor nuclear factor kappa B |
Increased nicotinamide adenine dinucleotide phosphate oxidase activity |
Blood-flow abnormalities |
Alteration of vascular permeability |
Induction of angiogenesis |
Organ fibrosis |
Capillary occlusion |
Induction of inflammatory mediators |
Stimulation of oxidative stress |
Table 2 Inflammatory cytokine-related effects potentially involved in the development and progression of renal injury in diabetes
Increase expression and synthesis of chemokines, adhesion molecules, transcription factors, cytokines, growth factors and mediators of inflammation |
Alteration of synthesis of prostaglandins and hyaluronan |
Stimulation of oxidative stress |
Induction of intraglomerular hemodynamic abnormalities |
Increase of vascular endothelial cell permeability |
Induction of cell proliferation and contraction, and inhibition of endothelium relaxation |
Increase fibronectin expression |
Induction of cell apoptosis and necrosis |
Induction of glomerular hypertrophy |
Stimulation of plasminogen activator inhibitor-1 production |
Reduction of tissue factor inhibitor and thrombomodulin expression |
Stimulation of inflammatory cells recruitment and activation |
Induction of major histocompatibility complex antigen expression |
- Citation: Luis-Rodríguez D, Martínez-Castelao A, Górriz JL, Álvaro F, Navarro-González JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes 2012; 3(1): 7-18
- URL: https://www.wjgnet.com/1948-9358/full/v3/i1/7.htm
- DOI: https://dx.doi.org/10.4239/wjd.v3.i1.7